Workers in nursing hospitals and nursing facilities at the public health center in Dobong-gu, Seoul, are waiting in the adverse reaction observation room after receiving the AstraZeneca (AZ) vaccine. Photo co-recruitment group
The number of new coronavirus infectious diseases (Corona 19) vaccine first vaccinated was 11,131 as of 0 o’clock on the 7th. The cumulative number of inoculations was 314,656, indicating that 0.6% of the total population completed the first vaccination.
According to the Corona 19 Vaccination Response Promotion Team on the 7th, the number of Corona 19 primary vaccinations as of 0 o’clock on the 7th increased to 31,4656 people, an increase of 111.31 people. Of these, the number of AstraZeneca (AZ) vaccinations was 3,09387, and 5,269 of Pfizer vaccinations.
It is estimated that 0.6% of the total of 58,82,5932 people (as of the end of January 2021) received the first vaccination. Except for the Janssen vaccine, which will be introduced in the future, the remaining vaccines need to be vaccinated twice to form immunity.
The area of 11,131 new primary inoculations is 2158 in Seoul, 1288 in Busan, 875 in Daegu, 617 in Incheon, 1606 in Gwangju, 375 in Daejeon, 608 in Ulsan, 30 in Sejong, 2843 in Gyeonggi, 279 in Gangwon, Chungbuk 330, Chungnam 486, Jeonbuk 1797, Jeonnam 528, Gyeongbuk 821, Gyeongnam 2037, and Jeju 453.
The number of cases reported as adverse reactions after the Corona 19 vaccination recorded 3689 cases, an increase of 806 cases as of 0 o’clock on the day. Of the 806 newly reported cases, 794 were mild cases such as headache, fever, nausea, and vomiting, which can be common after vaccination.
In addition, 9 suspected cases of anaphylaxis (33 cases accumulated), 2 cases of severe suspicion such as convulsions (5 cases accumulated), and 1 case of death (8 cases accumulated) were reported. Anaphylaxis suspected cases are classified into three categories: anaphylaxis shock, anaphylaxis, and anaphylaxis.
Currently, there are 32 cases of anaphylaxis-like reaction among suspected cases of anaphylaxis and 1 case of suspected anaphylactic shock. Severe adverse reactions with a risk of death are classified as anaphylaxis shock and refer to cases in which an acute allergic reaction occurs within 30 minutes after vaccination.
Other serious suspicious cases are cases of severe adverse reactions such as convulsions and admission to the intensive care unit. However, the current abnormal case report is a simple report count for which the causality of vaccination has not been confirmed, and epidemiological investigations are conducted only for severe cases such as death and anaphylaxis.
Reporter Lee Ji-young [email protected]
